Collegium Pharma
COLL35.7400.03% ( +0.010 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Collegium Pharma(COLL) predict that the Revenue is 193.52 M (+8.87%), Beat estimate;the EBIT is 103.42 M (+376.9%), Beat estimate;the EPS is 0.4 (+471.4%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.19B8.87%
0.18B3.77%
+0.01B5.10%
EBITExceed expectations
0.10B376.89%
0.10B350.83%
+0.01B26.06%
EPSMiss expectations
0.4471.43%
0.44528.57%
-0.040057.14%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 6, 2026
Estimate Revenue200.95 M
Estimate EBIT106.17 M
Estimate EPS0.51
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf